Immunological phenotype analysis of patients with Fanconi's anaemia and their family members
- PMID: 9691145
- DOI: 10.1159/000040861
Immunological phenotype analysis of patients with Fanconi's anaemia and their family members
Abstract
In contrast to patients affected with Fanconi's anaemia (FA), who are homozygotes, parental heterozygotes are generally considered normal. In this preliminary work the main immunological phenotypes of circulating mononucleated cells were studied, both in homozygous and heterozygous subjects. The statistical analysis of results showed that two sets of variables may be distinguished: (a) the first set, including CD20, CD4, CD8 cell markers and CD20/CD3 and CD4/CD8 ratios, that was able to differentiate between FA patients and the other subject groups; (b) the second set, including CD25, HLA-DR, HLA-DP, HLA-DQ cell markers, that was able to differentiate healthy subjects from the other groups. Therefore, in contrast with the literature data, immunological abnormalities may already be present in parental heterozygotes of FA patients. These subjects displayed a reduced number of cells expressing both specific (CD25) and non-specific (HLA) antigens. This defect was more severe in FA homozygous patients, who showed, in addition, a reduced total lymphocyte count, reduced levels of T helper (CD4+) and B lymphocytes (CD20+), and a reduced CD4+/CD8+ cell ratio. In conclusion, our results suggest the presence of a grading of immunological defects in FA patients and family members. Our suggestion needs to be confirmed by functional studies.
Similar articles
-
Prognostic value of the immunological phenomena and relationship with clinicopathological characteristics of the tumor--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ lymphocytes in squamous cell laryngeal carcinoma. Part II.Folia Histochem Cytobiol. 2011;49(4):593-603. Folia Histochem Cytobiol. 2011. PMID: 22252753
-
[Lymphocyte activation markers in patients with ovarian cancer].Ginekol Pol. 2012 Oct;83(10):737-43. Ginekol Pol. 2012. PMID: 23383558 Polish.
-
The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.Folia Histochem Cytobiol. 2011;49(4):579-92. Folia Histochem Cytobiol. 2011. PMID: 22252752
-
Reference values for peripheral blood lymphocyte phenotypes applicable to the healthy adult population in Switzerland.Eur J Haematol. 2004 Mar;72(3):203-12. doi: 10.1046/j.0902-4441.2003.00199.x. Eur J Haematol. 2004. PMID: 14962239
-
Fanconi's anaemia and pregnancy.Br J Haematol. 1991 Mar;77(3):410-8. doi: 10.1111/j.1365-2141.1991.tb08593.x. Br J Haematol. 1991. PMID: 2012768 Review.
Cited by
-
Impaired immune function in children with Fanconi anaemia.Br J Haematol. 2011 Jul;154(2):234-40. doi: 10.1111/j.1365-2141.2011.08721.x. Epub 2011 May 4. Br J Haematol. 2011. PMID: 21542827 Free PMC article.
-
Impaired immune function in children and adults with Fanconi anemia.Pediatr Blood Cancer. 2017 Nov;64(11):10.1002/pbc.26599. doi: 10.1002/pbc.26599. Epub 2017 May 30. Pediatr Blood Cancer. 2017. PMID: 28557197 Free PMC article.
-
Deletion of Fanca or Fancd2 dysregulates Treg in mice.Blood. 2014 Mar 20;123(12):1938-47. doi: 10.1182/blood-2013-09-528018. Epub 2014 Feb 5. Blood. 2014. PMID: 24501220 Free PMC article.
-
Fanconi anemia proteins and their interacting partners: a molecular puzzle.Anemia. 2012;2012:425814. doi: 10.1155/2012/425814. Epub 2012 Mar 29. Anemia. 2012. PMID: 22737580 Free PMC article.
-
Inflammatory reactive oxygen species-mediated hemopoietic suppression in Fancc-deficient mice.J Immunol. 2007 Apr 15;178(8):5277-87. doi: 10.4049/jimmunol.178.8.5277. J Immunol. 2007. PMID: 17404312 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials